The Relationship Between Colonic Macrophages and MicroRNA-128 in the Pathogenesis of Slow Transit Constipation
- PMID: 25749934
- DOI: 10.1007/s10620-015-3612-1
The Relationship Between Colonic Macrophages and MicroRNA-128 in the Pathogenesis of Slow Transit Constipation
Abstract
Background: Recent evidence suggests that colonic macrophages and microRNAs play important roles in motor activity in the gastrointestinal tract. However, there are almost no data concerning colonic macrophages and microRNAs in slow transit constipation.
Aim: The purpose of this study was to investigate colonic macrophages and microRNA-128 expression in the pathogenesis of slow transit constipation in colon tissues.
Methods: Full-thickness colonic specimens from patients undergoing surgery for slow transit constipation, due to refractoriness to other therapeutic interventions (n = 25), were compared to controls (n = 25), and the number of colonic macrophages (as evaluated by specific monoclonal antibodies) was counted. Gene expression analysis of microRNA-128 was performed by microRNA microarray and qRT-PCR. Lastly, bioinformatics analysis, coupled with luciferase reporter assays, was used to investigate the mRNA transcript(s) targeted by microRNA-128.
Results: Compared to controls, 20 of 25 slow transit constipation patients (80 %) had significantly higher numbers of macrophages in colonic specimens, coupled with down-regulation of microRNA-128. Linear regression analyses showed a significant negative correlation between macrophage number and microRNA-128 expression level. Among 83 bioinformatically predicated candidates, mitogen-activated protein kinase 14 (p38α) was validated to be a direct target of microRNA-128 in human intestinal epithelial cells.
Conclusions: This study presents evidence for the negative correlation of macrophage number and microRNA-128 expression, in slow transit constipation patients, representing a possible mechanism of impaired gastrointestinal motility.
Similar articles
-
Colonic mast cells in controls and slow transit constipation patients.Aliment Pharmacol Ther. 2011 Jul;34(1):92-9. doi: 10.1111/j.1365-2036.2011.04684.x. Epub 2011 May 3. Aliment Pharmacol Ther. 2011. PMID: 21539589
-
Altered periodic rectal motor activity: a mechanism for slow transit constipation.Neurogastroenterol Motil. 2001 Dec;13(6):591-8. doi: 10.1046/j.1365-2982.2001.00292.x. Neurogastroenterol Motil. 2001. PMID: 11903920 Clinical Trial.
-
Scintigraphic assessment of slow transit constipation with special reference to right- or left-sided colonic delay.Colorectal Dis. 2004 Nov;6(6):499-505. doi: 10.1111/j.1463-1318.2004.00694.x. Colorectal Dis. 2004. PMID: 15521943
-
Slow-transit constipation: evaluation and treatment.ANZ J Surg. 2007 May;77(5):320-8. doi: 10.1111/j.1445-2197.2007.04051.x. ANZ J Surg. 2007. PMID: 17497967 Review.
-
Slow transit constipation in children.J Paediatr Child Health. 2001 Oct;37(5):426-30. doi: 10.1046/j.1440-1754.2001.00692.x. J Paediatr Child Health. 2001. PMID: 11885703 Review.
Cited by
-
MicroRNA regulation of enteric nervous system development and disease.Trends Neurosci. 2025 Apr;48(4):268-282. doi: 10.1016/j.tins.2025.02.004. Epub 2025 Mar 14. Trends Neurosci. 2025. PMID: 40089421 Review.
-
Micro-organic basis of functional gastrointestinal (GI) disorders: Role of microRNAs in GI pacemaking cells.Indian J Gastroenterol. 2021 Apr;40(2):102-110. doi: 10.1007/s12664-021-01159-7. Indian J Gastroenterol. 2021. PMID: 33738768 No abstract available.
-
Efficacy and MicroRNA-Gut Microbiota Regulatory Mechanisms of Acupuncture for Severe Chronic Constipation: Study Protocol for a Randomized Controlled Trial.Front Med (Lausanne). 2022 Jun 28;9:906403. doi: 10.3389/fmed.2022.906403. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35836948 Free PMC article.
-
Characterization of Circular RNA Expression Profiles in Colon Specimens of Patients with Slow Transit Constipation.Dis Markers. 2022 Jun 10;2022:3653363. doi: 10.1155/2022/3653363. eCollection 2022. Dis Markers. 2022. PMID: 35730015 Free PMC article.
-
Role of microRNAs in gastrointestinal smooth muscle fibrosis and dysfunction: novel molecular perspectives on the pathophysiology and therapeutic targeting.Am J Physiol Gastrointest Liver Physiol. 2016 Apr 1;310(7):G449-59. doi: 10.1152/ajpgi.00445.2015. Epub 2016 Jan 28. Am J Physiol Gastrointest Liver Physiol. 2016. PMID: 26822916 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical